Meyer-Rienecker H, Jenssen H, Kohler H, Gunther J
J Neurol. 2010; 211(3):229-40.
PMID: 20563772
DOI: 10.1007/BF00313233.
Eckstein R, Mempel W, Hannig K, Wilmanns W
Blut. 1980; 41(6):459-64.
PMID: 7448433
DOI: 10.1007/BF01007772.
Sunba M, Rahi A, MORGAN G, HOLBOROW E
Br J Ophthalmol. 1980; 64(8):576-90.
PMID: 7426575
PMC: 1043764.
DOI: 10.1136/bjo.64.8.576.
Hoffmann W, Kaufmann R, Steiner R, Werner W
Br J Cancer. 1981; 43(5):598-609.
PMID: 7248145
PMC: 2010696.
DOI: 10.1038/bjc.1981.89.
Wiatr E, Rykiel B, Rowinska E, Roszkowski W
J Cancer Res Clin Oncol. 1982; 103(3):287-92.
PMID: 7118991
DOI: 10.1007/BF00409704.
Lymphocyte supernatants and the electrophoretic mobility of erythrocytes: further experience of cancer diagnosis.
Dyson J, Watkinson A, Jones W, Corbett P, JOSLIN C
Br J Cancer. 1980; 42(3):448-54.
PMID: 7000116
PMC: 2010423.
DOI: 10.1038/bjc.1980.257.
Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers--where do we go from here?.
Bagshawe K
Br J Cancer. 1983; 48(2):167-75.
PMID: 6192836
PMC: 2011455.
DOI: 10.1038/bjc.1983.172.
Cellular immunity to encephalitogenic peptide in tumour-bearing mice.
Yong W, HALLIDAY W
Br J Cancer. 1982; 45(5):754-61.
PMID: 6177329
PMC: 2011013.
DOI: 10.1038/bjc.1982.117.
Interaction of myelin basic protein with mononuclear cells: the primary reaction for the MEM and EMT tests.
Goppelt M, Grol M, Pingoud A, Schumacher K
Br J Cancer. 1981; 44(6):838-45.
PMID: 6173054
PMC: 2010855.
DOI: 10.1038/bjc.1981.282.
Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
Hoffmann W, Werner W, Steiner R, Kaufmann R
Br J Cancer. 1981; 43(5):588-97.
PMID: 6166306
PMC: 2010692.
DOI: 10.1038/bjc.1981.88.
A common tumour-specific antigen: III. Preparation of small fragments incorporating the cell-sensitizing determinant.
Dickinson J, McDermott J, Smith J, CASPARY E
Br J Cancer. 1980; 42(2):266-74.
PMID: 6158971
PMC: 2010373.
DOI: 10.1038/bjc.1980.226.
Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.
Balding P, Light P, Preece A
Br J Cancer. 1980; 41(1):73-85.
PMID: 6153900
PMC: 2010169.
DOI: 10.1038/bjc.1980.9.
Lymphocyte sensitization in sarcoidosis.
CASPARY E, Field E
Br Med J. 1971; 2(5754):143-5.
PMID: 5581493
PMC: 1795611.
DOI: 10.1136/bmj.2.5754.143.
Lymphocyte sensitization in malignant neoplasia.
CASPARY E
Proc R Soc Med. 1972; 65(7):636-8.
PMID: 5085945
PMC: 1644213.
Lymphocyte sensitization to carcinoembryonic antigen (Gold) with special reference to multiple sclerosis.
Field E, CASPARY E
Br Med J. 1972; 4(5835):261-3.
PMID: 5083886
PMC: 1788857.
DOI: 10.1136/bmj.4.5835.261.
Identification of a tumour antigen.
Carnegie P, CASPARY E, Field E
Biochem J. 1972; 126(3):5P-6P.
PMID: 5075270
PMC: 1178445.
DOI: 10.1042/bj1260005p.
Immunodiagnosis of cancer.
Field E, CASPARY E, Shepherd R
Br Med J. 1972; 3(5827):641-2.
PMID: 5071703
PMC: 1785957.
DOI: 10.1136/bmj.3.5827.641.
Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor.
Field E, CASPARY E
Br J Cancer. 1972; 26(3):164-73.
PMID: 5047140
PMC: 2008474.
DOI: 10.1038/bjc.1972.23.
The mechanism of antigen-induced electrophoretic mobility reduction of guinea-pig macrophages.
CASPARY E
Clin Exp Immunol. 1972; 11(2):305-9.
PMID: 5040311
PMC: 1553633.
Immunological activity of blood lymphocyte fractions. A study by the macrophage electrophoretic mobility method.
MINDERHOUD J, Smith J
Clin Exp Immunol. 1972; 10(4):571-9.
PMID: 5034245
PMC: 1713116.
